KRSNAA563.45

Krsnaa Diagnostics Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersSURAKSHAHEALTHXNEPHROPLUS3BBLACKBIOMcap ₹1,828 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations619.6717.2772.8815.3
Other Income16.825.543.446.7
Total Income636.4742.7816.2862.0
Expenses
+ Cost of Materials Consumed141.0169.3179.0181.8
+ Employee Benefit Expense111.5136.8140.5141.0
+ Finance Costs16.524.734.442.9
+ Depreciation & Amortisation74.588.390.596.8
+ Other Expenses222.9221.0241.4274.1
Total Expenses566.4640.0685.7736.6
EBITDA144.2190.1211.9218.5
EBIT69.7101.8121.4121.7
Profit
PBT before Exceptional Items70.0102.7130.4125.5
Pretax Income70.0102.7130.4125.5
+ Current Tax10.821.824.424.4
+ Deferred Tax2.43.34.53.6
Tax Expense13.225.128.927.9
+ Share of Associates & JVs0.00.0-0.1-0.1
Net Income56.877.6101.497.5
+ Net Income — Continuing Ops56.877.6101.597.5
+ Other Comprehensive Income-0.10.50.20.2
Total Comprehensive Income56.778.1101.697.6
Net Income to Common56.877.6101.482.2
Per Share
Basic EPS17.9024.0431.3030.06
Diluted EPS17.3123.5630.8829.65
Other Comprehensive Income — detail
+ Other Comprehensive Income0.50.20.2
+ Items NOT to be Reclassified to P&L-0.20.60.30.2
+ Tax on Items NOT to be Reclassified0.10.10.1
+ Tax on Items NOT to be Reclassified — alt tag-0.0
Comprehensive Income — Owners of Parent56.778.1101.665.9
Per Share — as-filed variants
Basic EPS — Continuing Operations17.9024.0431.3030.06
Diluted EPS — Continuing Operations17.3123.5630.8829.65
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit478.6547.9593.7633.5
Gross Margin %77.2476.4076.8377.70
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)70.0102.7130.4125.5
Net Income Adj (tax-effected)56.877.6101.497.5
EPS Adj17.9024.0431.3030.06
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value5.005.005.005.00
Filed Debt Equity0.01
Filed Dscr0.03
Paid Up Equity Capital16.116.116.216.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.